Trial · NCT00058240
Adverse events36
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 36
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Absolute Neutrophil Count | Investigations | Dose Levels 1-3 | 30 | 40 | 30 |
| other | Absolute Neutrophil Count | Investigations | Dose Level 4 | 16 | 16 | 16 |
| other | WBC | Investigations | Dose Levels 1-3 | 0 | 40 | 0 |
| other | WBC | Investigations | Dose Level 4 | 11 | 16 | 11 |
| other | Platelets | Investigations | Dose Levels 1-3 | 15 | 40 | 15 |
| other | Platelets | Investigations | Dose Level 4 | 7 | 16 | 7 |
| other | Hemorhage | Vascular disorders | Dose Levels 1-3 | 3 | 40 | 3 |
| other | Hemorhage | Vascular disorders | Dose Level 4 | 1 | 16 | 1 |
| other | Hypotension | Vascular disorders | Dose Levels 1-3 | 4 | 40 | 4 |
| other | Hypotension | Vascular disorders | Dose Level 4 | 1 | 16 | 1 |
| other | Hypoxia | Respiratory, thoracic and mediastinal disorders | Dose Levels 1-3 | 6 | 40 | 6 |
| other | Hypoxia | Respiratory, thoracic and mediastinal disorders | Dose Level 4 | 3 | 16 | 3 |
| other | Diarrhea | Gastrointestinal disorders | Dose Levels 1-3 | 16 | 40 | 16 |
| other | Diarrhea | Gastrointestinal disorders | Dose Level 4 | 12 | 16 | 12 |
| other | Abdominal pain/cramping | Gastrointestinal disorders | Dose Levels 1-3 | 2 | 40 | 2 |
| other | Abdominal pain/cramping | Gastrointestinal disorders | Dose Level 4 | 1 | 16 | 1 |
| other | AST SGOT(serum glutamic oxaloacetic transaminase) or ALT, SGPT (serum glutamic pyruvic transaminase) | Investigations | Dose Levels 1-3 | 13 | 40 | 13 |
| other | AST SGOT(serum glutamic oxaloacetic transaminase) or ALT, SGPT (serum glutamic pyruvic transaminase) | Investigations | Dose Level 4 | 3 | 16 | 3 |
| other | Bilirubin | Investigations | Dose Levels 1-3 | 3 | 40 | 3 |
| other | Bilirubin | Investigations | Dose Level 4 | 1 | 16 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00058240/events